MDMA-Assisted Psychotherapy for Treatment Resistant PTSD in Adolescents

Summary

The primary objective of this study is to determine the safety and feasibility of 3,4-methylenedioxymethamphetamine (MDMA) -assisted psychotherapy to treat resistant post-traumatic stress disorder (PTSD). The secondary objectives are the exploration of effectiveness for treatment-resistant PTSD, symptoms of depression, and anxiety symptoms.

Timeline

Start

2025-07-01

Primary completion

2026-01-31

Completion

2026-12-31

Outcome

Outcome not reported

Stopped: “Under review with FDA”

Drugs

Indications